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Light/dark taskThere is growing interest in zebraﬁsh as a model organism in behavioral pharmacology research. Several
anxiety behaviors have been characterized in zebraﬁsh, but the effect of anxiolytic drugs on these parameters
has been scarcely studied. The purpose of this work was to assess the predictive validity of acute treatment
with anxiolytic drugs on behavioral parameters of anxiety. In the ﬁrst task we simultaneously observed
behavior of adult zebraﬁsh on four parameters: height in the tank, locomotion, color, and shoal cohesion. The
second task was the assessment of light/dark preference for 5 min. The benzodiazepines clonazepam,
bromazepam, diazepam, and a moderate dose of ethanol signiﬁcantly reduced shoal cohesion. Buspirone
speciﬁcally increased zebraﬁsh exploration of higher portions of the tank. In the light/dark task, all
benzodiazepines, buspirone, and ethanol increased time spent in the light compartment. After treatment with
anxiolytics, ﬁsh typically spent more than 60 s and rarely less than 40 s in the light compartment whereas
controls (n=45) spent 33.3±14.4 s and always less than 60 s in the light compartment. Propranolol had no
clear effects in these tasks. These results suggest that light/dark preference in zebraﬁsh is a practical, low-cost,
and sensitive screening task for anxiolytic drugs. Height in the tank and shoal cohesion seem to be useful
behavioral parameters in discriminating different classes of these drugs.o conﬂicts of interest.
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Zebraﬁsh (Danio rerio) have many inherent advantages as a model
organism, such as low cost, easy handling and maintenance as
compared with other vertebrate models, and 70–80% genetic
homology to humans (Barbazuk et al., 2000; Goldsmith, 2004; Egan
et al., 2009). Although this degree of homology with humans is not as
high compared to rodents, it is favorable compared to invertebrates
such as Drosophila melanogaster and Caenorhabditis elegans. Despite
the increasing popularity of zebraﬁsh in neuroscience, behavioral
assessments in this model animal need further study.
In this species, behavior can be easily observed and quantiﬁed in a
controlled environment (Beis and Stainier, 2006; Miklósi and Andrew,
2006; Levin et al., 2007). The behavioral repertoire of zebraﬁsh is
complex and allows the development of a range of behavioralparameters (Gerlai et al., 2000; Zon and Peterson, 2005). Furthermore,
the characterization of zebraﬁsh behavior is important for the
generation of large-scale behavioral screenings and a system-level
analysis of how chemicals affect behavior. Such behavioral screening
tests may improve our understanding of neurobiology and drug action,
and accelerate the pace of psychiatric drug discovery (Berghmans et al.,
2007; Kokel and Peterson, 2008; Rihel et al., 2010). Recently, Rihel et al.
(2010) evaluated the effect of 3968 compounds on locomotor activity
and rest/wake regulation of larval zebraﬁsh, ﬁnding speciﬁc behavioral
ﬁngerprints for many psychotropic classes. However, the characteriza-
tion of more speciﬁc behavioral tasks is important for better use of
zebraﬁsh in the study of brain function.
Several measures of fear and anxiety have been proposed in
zebraﬁsh. Fear is deﬁned as a response to imminent threat (Craske et
al., 2009), which in zebraﬁsh has been studied as reactions to
predators and alarm pheromone, such as ﬂeeing, erratic movements,
freezing behavior, bottom-dwelling and crowding to form a dense
shoal (Pfeiffer, 1977). Gerlai et al. (2009) has established automated
measures of zebraﬁsh escape from animated images of sympatric
predators. Freezing behavior also increases with caffeine treatment,
exposure to alarm substances (Egan et al., 2009) or to aversive
environments (Blaser et al., 2010).
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threats, usually manifested as avoidance behavior (Craske et al, 2009).
In zebraﬁsh, Levin et al. (2007) have proposed that height in the tank
may be a useful measure of anxiety that resembles thymogtaxis
observed in rodents. Indeed, acute nicotine (Levin et al., 2007),
buspirone (Bencan et al., 2009), and chronic ﬂuoxetine (Egan et al.,
2009) treatment reduce bottom-dwelling, but the results of the
benzodiazepines diazepam and chlordiazepoxidewere inconsistent in
this task (Bencan et al., 2009). Moreover, preference of zebraﬁsh for
dark along with aversion to light environments has been put forward
as a useful behavioral parameter (Serra et al., 1999; Maximino et al.,
2010) and is reduced after treatment with ﬂuoxetine, clonazepam,
buspirone and ethanol (Maximino et al, 2011). Another behavior that
may be related to anxiety and self-protection in zebraﬁsh is their
preference for being in groups, which is reduced by acute treatment
with ethanol (Gerlai et al., 2000; Gerlai, 2003). However, these
putative measures of anxiety have been poorly characterized in terms
of face and predictive validity, especially regarding response speci-
ﬁcity to different classes of anxiolytics.
Anxiolytics are generally divided into two groups of medications,
benzodiazepines (BDZs) and non-benzodiazepines (barbiturates, pro-
pranolol, and buspirone) (Menard and Treit, 1999; Bianchi et al., 2009).
Benzodiazepines potentiate GABAA receptor function by increasing
channel opening frequency, producing hypnotic effects by acting on α1
(Mckernan et al., 2000) and anxiolytic activity by acting on α2 subunits
(Löw et al., 2000). Buspirone exerts anxiolytic effects by acting as a
partial agonist at serotonin 5-HT1A receptors (Ohlsen and Pilowsky,
2005). Ethanol also has acute anxiolytic effects, probably mediated by
GABAA receptors (Radcliffe et al., 1999; Kumar et al., 2009), with
depressant effects on the central nervous system at higher doses.
Propranolol is a non-selective β1- and β2-adrenergic antagonist
with anxiolytic effects only for performance and somatic anxiety
(Granville-Grossman and Turner, 1966; Tyrer and Lader, 1974).
Our objective was to assess the effect of anxiolytic drugs on putative
behavioral parameters of anxiety in zebraﬁsh. With the goal to develop
fast, simple and valid tasks and endpoints to assess anxiolytic action, we
used a protocol (the Group Behavior Task, GBT) that allows evaluating
shoal cohesion, height in the tank and locomotion simultaneously,
which are parameters putatively related to anxiety in zebraﬁsh. Thus,
we investigated the behavioral responses of zebraﬁsh acutely treated
with different anxiolytics in the GBT and the light/dark task.
2. Material and methods
2.1. Animals and housing
A total of 391 adult male and female ‘wild type’ (short ﬁn)
zebraﬁsh (Danio rerio) were obtained from a commercial supplier
(Red Fish, Porto Alegre, Brazil). All ﬁsh were acclimated for at least
twoweeks in the laboratory environment and housed in groups of 30–
50 ﬁsh in a 50 L thermostat tank (28±2 °C) with water previously
treated with Tetra's AquaSafe® (to neutralize chlorine, chloramines
and heavy metals; pH 7.2; conductivity 501 μS, ﬁltered with Tetra
Whisper® PF10) and continuously aerated (7.2 mg O2/L). Fish were
kept on a 14–10 h day/night cycle and fed three times a day with
commercial ﬂakes and supplemented with live brine shrimp.
All protocols were reviewed and approved by an Institutional
Review Committee for the use of Human or Animal Subjects (110/08-
CEUA-PUCRS) and the procedures are in compliance with the National
Institutes of Health Guide for Care and Use of Laboratory Animals
(Publication No. 85-23, revised 1985).
2.2. Chemicals
Clonazepam (Rivotril®), bromazepam (Lexotan®), diazepam
(União Química, Brazil), and ethanol were purchased from commoncommercial suppliers. Buspirone and propranolol were from Sigma-
Aldrich (USA).
2.3. Treatments
Three ﬁsh were placed into a beaker ﬁlled with 300 mL of the
water from the respective test tanks (with the corresponding drug
concentration) for a pretreatment of 10 min. Oxygen levels remained
adequate during this treatment (8 ppm). In the GBT, drug treatment
during the task was maintained as indicated. Pilot studies comparing
10, 30, and 50 min indicated that 10 min were sufﬁcient to induce
clear behavioral effects for all drugs tested. Drug concentrations
(clonazepam 0.3 mg/L; bromazepam 1.5 mg/L; diazepam 0.16 mg/L;
buspirone 1 and 3 mg/L; propranolol 3 mg/L) were determined based
on pilot drug response curves and the relative potency of benzodi-
azepines. Ethanol concentrations (0.25 and 0.5%) were chosen based
on previous data (Gerlai et al., 2000, 2006).
Raters (interrater reliability rN0.90, Spearman test) were blind to
treatments, which were administered by another researcher, and a
control group was included in every experiment.
2.4. Behavioral apparatus
All procedures were performed in an isolated room. One day
(24 h) prior to the experiments, both male and female ﬁsh
(approximately 1:1 distribution) were moved to the experimental
roomwith identical conditions to the ﬁsh housing apparatus to reduce
environmental variance during behavioral assays.
The Group Behavior Task (GBT) was performed according to Piato
et al. (2011). Test tanks (24×8×20 cm, length×width×height) with
2.7 L of water (15 cm high) were used for simultaneous evaluation of
height in the tank, locomotion, color, and shoal cohesion. Water
temperature was maintained with heaters. The lateral and back sides
were visually blocked with white opaque self-adhesive plastic ﬁlm to
reduce the inﬂuence of the surrounding area and to facilitate
observation.
For the light/dark task, a glass tank (18×9×7 cm, length×width×-
height, adapted from Rawashdeh et al., 2007) was divided by a sliding
guillotine-type partition (9×7 cm) in two equally sized dark and white
compartments using black or white self-adhesive ﬁlm externally
covering walls, ﬂoor and the corresponding sides of the partition. The
tank water level was 3 cm and the partition was raised 1 cm above the
tank ﬂoor to allow zebraﬁsh to swim freely from one side of the tank to
the other.
2.5. Behavioral scores in the GBT
2.5.1. Height in the tank
The position (bottom×middle×upper levels) was considered an
index of anxiety, similar to the position near thewall versus the center
of an open ﬁeld with rodents (Levin et al., 2007; Egan et al., 2009).
Fish position in the test tank experiment was noted according to
the following scores during 1 min-observations: 1—only in the
bottom third of the tank; 2—preference for the lower two thirds of
the tank; 3—similar times exploring the three thirds; 4—preference
for the upper two thirds; and 5—only in the upper third. This score has
a 0.90 correlation (Spearman test) with an objective measure using
stopwatch performed by separate and independent observers blinded
to each others' results (n=65).
2.5.2. Locomotion
Locomotor activity was used as a general index of behavioral
excitation/inhibition. Activity was evaluated by comparing to ‘internal
control’ ﬁsh, using the following scores: 1—virtually immobile; 2—
slower than normal; 3—normal; 4—increased locomotion; and 5—
intense locomotion. This score has a 0.50 correlation (Spearman test)
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tank divided in 9 rectangles) performed by separate and independent
observers blinded to each others' results (n=63). Although this
correlation level is only moderate, it is acceptable to detect gross
changes in locomotion, as in our pilot experiments with higher doses
of benzodiazepines.
2.5.3. Color
Zebraﬁsh change their color in response to certain stimuli. Fish
that exhibit signs of fear (e.g., freezing or erratic movement) quickly
become pale, especially when the background is light. When ﬁsh are
more excited or aggressive, they become more chatoyant (Gerlai,
2003).
Fish color was rated visually by comparing to ‘internal control’ ﬁsh
and scored as follows: 1—pale; 2—lighter than normal but not pale; 3
—normal; 4—darker than normal but not chatoyant with dark-blue
stripes; and 5—chatoyant with dark-blue stripes.
2.5.4. Shoal cohesion
Zebraﬁsh prefer swimming in groups and group aggregation is
termed shoal cohesion (Engeszer et al., 2007; Miller and Gerlai, 2007;
Saverino and Gerlai, 2008). This behavioral strategy is thought to be
effective against predators in several ﬁsh species (Detrich et al., 1999;
Gerlai et al., 2000). In contrast to other studies using only one ﬁsh
during experiments, placing three in the test tank allows the
maintenance of their natural shoal behavior.
Shoal cohesion was measured individually by comparing to
‘internal control’ ﬁsh (i.e., a group of three untreated ﬁsh habituated
in an independent tank) according to the following scores: 1—
complete lack of group cohesion or ﬁsh interaction; 2—loose or partial
shoaling behavior; 3—normal distance and shoaling behavior com-
pared to ‘internal control’; and 4—increased shoal cohesion. This score
has a−0.81 correlation (Spearman test) with an objective measure of
distance between the 3 ﬁsh (using Image J software) in pictures
extracted from video recordings every 15 s for 5 min. This analysis
was performed by separate and independent observers blinded to
each others' results (n=55).
2.6. GBT experiments
GBT experiments were repeated four times (for four groups of
three ﬁsh), totaling 12 ﬁsh for each drug concentration.
2.6.1. Experiment 1: effects of benzodiazepines, buspirone and ethanol in
the GBT
Firstly, each drug was prepared directly in the test tank (2.7 L).
Three ﬁsh were placed into a beaker ﬁlled with 300 mL of the water
from the respective test tanks (with the corresponding drug) for a
pretreatment of 10 min. After that ﬁsh were gently placed in the tank
and observed for 10 min. A separate group underwent the same
procedure in a test tank without drugs and was called ‘water control’.
Raters were blind to these treatment groups. Another group of three
ﬁsh without drug treatment was used as a reference of normal
behavior (e.g., locomotion and color) to help the rater and was called
‘internal control’.
Behavioral characteristics of zebraﬁsh were evaluated during
exposure to the test tank after the pretreatment period. During the
task, ﬁsh were observed by a rater blinded to treatments and ‘water
control’ in minutes 1, 2, 3, 4, 5, and 10.
2.6.2. Experiment 2: effect of exposure to drugs during the task in the
GBT
The same apparatus of experiment 1 was used. After 10 min of
drug pretreatment, three ﬁsh were transferred to the test tank and
analyzed at minutes 1, 2, 3, 4, 5, and 10. The same procedure was also
conducted in the presence (continuous treatment) or absence ofdrugs in the test tank during the experiment after 10 min pre-
treatments. This procedure was performed to examine if the presence
of the drug during the task was required for the observed effect.
2.6.3. Experiment 3: effects of drugs in the GBT during 15 min without
pretreatment
Each drug was prepared directly in the test tank (2.7 L). Three ﬁsh
were placed to the GBT and analyzed during 15 min with the
anxiolytic drugs. This experiment was performed to evaluate the
time required for drugs to induce their effects as an indirect measure
of drug distribution.
2.6.4. Experiment 4: effect of acute stress induced by a sinker on ﬁsh
treated with buspirone in the GBT
Buspirone was prepared directly in the test tank (2.7 L). Three ﬁsh
were placed to the GBT and analyzed during 10 min. After 5 min of
observation a sinker (15 g) was dropped into the tank and behavior
was analyzed for more 5 min. This procedure allowed assessing if the
effect of buspirone on increasing exploration of the top of the tank
was reversible and not due to an inability to swim at the bottom of the
tank.
2.7. Light/dark task
Zebraﬁsh show a marked preference for dark zones (Serra et al.,
1999; Blank et al., 2009; Maximino et al., 2010). Based on a similar
innate aversion of rodents to brightly illuminated areas (Bourin and
Hascoët, 2003), the light/dark task is classically used to evaluate the
effect of anxiolytics in rodents (Hascoët et al., 2001).
Fish were placed in the light zone of the apparatus with drug-free
water and the followingmeasures were recorded for 5 min: 1) latency
to the ﬁrst entry in the dark compartment; 2) time spent in the light
compartment; and 3) number of crossings between compartments.
The apparatus was ﬁlled with 3 cm of water. This shallow tank
restricts bottom-dwelling, which is a well established anxiety
behavior in a new environment. In this way, the main protective
strategy is black preference, which is the measure used in this task.
2.7.1. Experiment 5: effects of benzodiazepines, buspirone and ethanol in
the light/dark task
After drug pretreatment of 10 min in a beaker, ﬁsh were
individually placed at the white side of the tank and allowed to
swim freely between compartments. The time spent on each
compartment and the number of crossings were recorded during
5 min. The latency to ﬁrst enter in the dark compartment was also
measured.
2.8. Statistical analysis
All score data were expressed as median+interquartile range.
Differences between control and treated groups were evaluated by a
Kruskal–Wallis followed by a Mann–Whitney test. In the light/dark
task, differences between control and treated groups were evaluated
by one-way ANOVA followed by a Dunnett post hoc test. SPSS 16.0 for
Windows was used, and a signiﬁcance level of pb0.05 was adopted.
3. Results
3.1. Experiment 1: effects of benzodiazepines, buspirone, and ethanol in
the GBT
Buspirone signiﬁcantly (pb0.001) increased height in the tank
score across all minutes (Fig. 1A), i.e., ﬁsh spent more time exploring
the upper part of the tank, without affecting shoal cohesion or
locomotion. In contrast, all benzodiazepines (clonazepam, bromaze-
pam and diazepam) and ethanol signiﬁcantly (pb0.001) reduced
Fig. 2. Effects of clonazepam (CZP 0.3 mg/L), bromazepam (BZP 1.5 mg/L), diazepam
(DZP 0.16 mg/L), buspirone (BUSP 3 mg/L), and ethanol (ETOH 0.5%) on height in the
test tank, shoal cohesion, and locomotion in the GBT. The ﬁsh were pretreated during
10 min with the above drugs and after that observed during 10 min in the tank with or
without drugs. Data of 5th min are expressed as median+interquartile range.
*pb0.001×control. Kruskal–Wallis followed by Mann–Whitney test. n=12.
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locomotion, except for a small effect of bromazepam reducing
locomotion (pb0.001). These effects were more pronounced at 5
and 10 min of observation. Only ethanol increased color score (darker
blue stripes, Fig. 1D). Propranolol had no effect on GBT endpoints
(data not shown). These results suggest that height and shoal
cohesion are anxiety parameters that are modulated by different
neurotransmitter systems and drugs.
3.2. Experiment 2: effect of exposure to drugs during the task in the GBT
We also tested if drug pretreatment (10 min) without drug
exposure during the taskwas sufﬁcient to produce behavioral changes
(Fig. 2). For simplicity, results are shown as median and interquartile
range only at min 5. All benzodiazepines produced reduction of shoal
cohesion with or without drug exposure during the task. The effect of
buspirone on height and ethanol on shoal cohesion were more
apparent with continuous treatment during the task (pb0.001 with X
without treatment during the task), but were still signiﬁcantly
different from control (pb0.001) with their respective pretreatments
without continuous exposure.
3.3. Experiment 3: effects of drugs in the GBT during 15 min without
pretreatment
Buspirone signiﬁcantly (pb0.001, Fig. 3A) increased height in the
tank at all time points compared to control group. Diazepam
signiﬁcantly (pb0.001, Fig. 3A) reduced height in the tank after min
8, except at min 11. Shoal cohesion was reduced by all benzodiaz-
epines after min 8 (pb0.001, Fig. 3B) and by ethanol at min 9, 10, 12,
and 15. The insert (Fig. 3B) shows the medians of min 10–15 perFig. 1. Effects of clonazepam (CZP 0.3 mg/L), bromazepam (BZP 1.5 mg/L), diazepam (DZP 0.
(Fig. 1A), shoal cohesion (Fig. 1B), locomotion (Fig. 1C) and color (Fig. 1D) in the GBT. The ﬁ
10 min in the tank with the same drug. Data are expressed as median+interquartile rangetreatment, including control group. No drug treatment signiﬁcantly
affected locomotion or color (data not shown, except for ethanol at all
time points). These results suggest that the pretreatment of 10 min
was appropriate.
3.4. Experiment 4: effect of acute stress induced by a sinker on ﬁsh
treated with buspirone in the GBT
Since the robust and immediate effect of buspirone on height in
the tank could be due to a non-speciﬁc effect on swimming behavior
(e.g. direct effect on swimming bladder), we evaluated if this effect
was reversible by acute stress (dropping a sinker in the tank at min 5),
leading to a fear reaction that make ﬁsh go to the bottom of the tank
(Egan et al., 2009). Buspirone treatment (only during the task)16 mg/L), buspirone (BUSP 3 mg/L), and ethanol (ETOH 0.5%) on height in the test tank
sh were pretreated during 10 min with the above drugs and after that observed during
. *pb0.001×control. Kruskal–Wallis followed by Mann–Whitney test. n=12.
Fig. 3. Effects of clonazepam (CZP 0.3 mg/L), bromazepam (BZP 1.5 mg/L), diazepam
(DZP 0.16 mg/L), buspirone (BUSP 3 mg/L), and ethanol (ETOH 0.5%) on height in the
test tank (Fig. 3A) and shoal cohesion (Fig. 3B) in the GBT during 15 min with the above
drugs. Data are expressed as median+interquartile range. *pb0.001×control.
Kruskal–Wallis followed by Mann–Whitney test. n=12. The insert (Fig. 3B) shows
median of min 10–15 per treatment, including control group.
Fig. 4. Effects of buspirone (1 mg/L) on height in the test tank (Fig. 4A) and locomotion
(Fig. 4B) and in the GBT during 10 min. After 5 min of observation a sinker was dropped
into the tank and behavior was analyzed for a further 5 min. Data are expressed as
median. Kruskal–Wallis followed by Mann–Whitney test. n=12.
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pretreatment (pb0.001, Fig. 4A). Immediately after stress induced
by a sinker (5'30" and 6'), ﬁsh moved towards the bottom of the tank
both in control and buspirone groups (Fig. 4A), returning to their
baseline levels afterwards. Compared to min 5, locomotion was
slightly, but signiﬁcantly reduced after dropping the sinker (Fig. 4B) in
both groups compared to their respective controls at min 6 only.
Other parameters were not affected (data not shown). This result
shows that the effects of buspirone were reversible by an anxiogenic
behavioral intervention, suggesting that the increased exploration of
the upper part of the tank is not due to non-speciﬁc effects of
buspirone on swimming behavior.
3.5. Experiment 5: light/dark task
In the light/dark task, the control group spent 33.3±14.4 s of 300 s
in the light compartment. All control ﬁsh spent less than 60 s in the
light compartment (Fig. 5A).
After 10 min of drug pretreatment, all benzodiazepines, buspirone,
the combination of diazepam and buspirone, and ethanol 0.5%, but not
0.25%, increased time spent in the light compartment (F(8,150)=13.9,
pb0.001, Fig. 5A). After treatment with anxiolytics or 0.5% ethanol,
ﬁsh typically spentmore than 60 s and very rarely less than 30 s in the
light compartment. Propranolol failed to affect behavior in this task.
The latency to the ﬁrst entry in the dark compartment and the
number of crossings was not altered by treatments (Fig. 5B and C,
respectively).
4. Discussion
The current study demonstrated that benzodiazepines and ethanol
speciﬁcally decreased shoal cohesion, whereas buspirone speciﬁcally
increased height in the tank in the GBT. These effects were present at
doses that did not signiﬁcantly affect other behavioral parameters,
such as locomotion and color (except for darker color with ethanol).
In contrast, the light/dark task was sensitive for all anxiolytics and
ethanol. Propranolol failed to affect anxiety-related behaviors in bothtasks. Thus, the light/dark task may be an interesting screening task
for anxiolytics, whereas shoal cohesion and height in the tank could
be useful endpoints to differentiate the type of anxiolytic response.
Zebraﬁsh have a natural tendency to initially remain at the bottom
of a novel environment (e.g., a test tank) and then gradually, over a
few minutes, explore the higher portions of the test tank (Levin et al.,
2007; Egan et al., 2009). The fear response of zebraﬁsh also includes
forming stronger shoal cohesion, freezing, and becoming pale
(Rehnberg and Smith, 1988; Gerlai et al., 2000). The exposure to the
new environment of a tank is not particularly alarming to produce
such behaviors, but the effects of benzodiazepines and ethanol on
shoal cohesion became apparent only after 3–4 min in the tank,
whereas the effect of buspirone is readily observed in the ﬁrst minute.
These distinct time courses and sensitivities to different drugs suggest
that the neurobiological systems underlying height in the tank and
shoal cohesion are quite independent, but differential kinetics of the
drugs tested may play a role in their observed behavioral proﬁle.
Bencan et al. (2009) ﬁrst showed that buspirone signiﬁcantly
increased zebraﬁsh exploration of the higher portions of the tank in a
5 min task at doses that did not have sedative effects. Moreover, in
this study chlordiazepoxide failed to affect this parameter and
diazepam slightly reduced bottom-dwelling, but not in a dose–
response fashion. Levin et al. (2007) also showed that nicotine
induced zebraﬁsh to stay in the upper part of the tank in a 5 min task,
and Egan et al. (2009) found that exposure to an alarm pheromone led
ﬁsh towards the bottom part. Our study indicates that height and
shoal cohesion represent distinct and independent anxiety/ defensive
behaviors.
The results of Fig. 3 showed that a 10 min exposure to drugs was
sufﬁcient to exert behavioral effects for all drugs. Also, our
preliminary results comparing 10 and 30 min of pretreatment did
not show signiﬁcant differences (data not shown). Of note, buspirone
had a surprisingly rapid behavioral effect on height in the tank (since
the ﬁrst minute of exposure). However, buspirone produced signif-
icant effects even when absent in the task apparatus both in the GBT
and in the light/dark task. Moreover, the effect of buspirone on height
in the tank was transiently reversed by an acute stress induced by
dropping a sinker in the tank, suggesting that it was not a non-speciﬁc
Fig. 5. Effect of clonazepam (CZP 0.3 mg/L), bromazepam (BZP 1.5 mg/L), diazepam (DZP 0.16 mg/L), buspirone (BUSP 3 mg/L), buspirone plus diazepam (BUSP+DZP, 3 mg/L and
0.16 mg/L, respectively), ethanol (ETOH 0.25% and 0.5%), and propranolol (PROP 3 mg/L) on time spent in the light compartment (Fig. 5A), number of crossings (Fig. 5B), and latency
for ﬁrst crossing (Fig. 5 C) in the light/dark task. Fig. 5A shows dot plot and means (−), where each dot represents one ﬁsh. Groups with ﬁlled dots were signiﬁcantly different from
the control group. Data are expressed as mean±S.E.M. One-way ANOVA followed by Dunnett post hoc test. n=9–19 for all groups, except for n=26 in 0.25% ethanol group and
n=45 in the control group.
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understand such a rapid onset of behavioral effects of buspirone in
zebraﬁsh.
Color was not a useful parameter for anxiety. Gerlai et al. (2000)
reported that increased color intensity was associated with aggres-
siveness in zebraﬁsh, resembling the alcohol-induced increase in
aggression reported in rodents and primates (Miczek et al., 1993). In
the present study, alcohol induced an increase in the intensity of color
in zebraﬁsh, but aggression parameters were not evaluated.
The light/dark task has been classically used as an anxiety test in
rodents. Anxiolytics have been found to increase time spent in the
light zone whereas anxiogenic drugs decrease it (Imaizumi et al.,
1994). Zebraﬁsh also prefer dark environments (Serra et al., 1999;
Egan et al., 2009; Blank et al., 2009), which make this parameter
potentially useful to assess the effects of anxiolytics. Our results
conﬁrmed this dark preference of zebraﬁsh and showed that
benzodiazepines, buspirone and ethanol were effective in increasing
time in the light zone. In contrast, propranolol, which is not clinically
effective as an anxiolytic, produced no effect in this task, suggesting
some speciﬁcity of the light/dark task for anxiolytics. The combination
of diazepam and buspirone failed to produce an additive effect,
suggesting that in the light/dark task these drugs may have a similar
neural substrate. Another possible explanation for this result is a
ceiling effect on the range of this behavior. It should be noted that inthe light/dark task the apparatus was quite different from the GBT and
that ﬁsh were tested alone. These results suggest that the light/dark
task may be useful for behavioral high-throughput screening of new
anxiolytic compounds, since it is quick, easily performed and allows
automated detectionmethods (e.g., videotracking). Besides predictive
validity, Maximino et al. (2010) also point out the face and construct
validity of this task.
For all drugs and in both tasks, pretreatment for 10 min in a beaker
and behavioral evaluation for 5–10 min without drug in the test tank
were adequate. However, ethanol and buspirone showed more
pronounced effects in the GBT with continuous treatment. These
results suggest that the protocol with pretreatment only can be used
for anxiolytic screenings (as for the light/dark task), but there may be
some effect reduction for some drugs in the GBT for pharmacokinetic
reasons.
5. Conclusion
Rodents have been preferred for anxiety models due to its genetic
and physiological similarities to the human system (West et al., 2000).
On the other hand, cheaper and more easily handled organism
models, such as Drosophila melanogaster and Caenorhabditis elegans,
are invertebrates. The ease of observation of various parameters,
genetic manipulation, and low cost may be advantages of the
486 D.L. Gebauer et al. / Pharmacology, Biochemistry and Behavior 99 (2011) 480–486zebraﬁsh to cover this gap between model animals for neuroscience
research (Guo, 2009). Moreover, the behavioral methods employed
here (the GBT and the light/dark task) generate different types of data,
in a practical, simple, inexpensive, safe, and reproducible manner. The
simplicity of these behavioral parameters and their capacity to detect
distinct and common behavioral changes with different anxiolytic
drugs should make them useful for anxiety assessment in zebraﬁsh.
Further studies are necessary to evaluate the effect of other drug
classes in these behavioral parameters in zebraﬁsh.
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